Patents
Patent applications related to cybersecurity witnessed zero average annual growth in the pharmaceutical industry since 2020
Credit: Bert van Dijk/Getty images.
Powered by
The global pharmaceutical industry experienced a zero annual average growth rate (AAGR) in the number of cybersecurity-related patent applications between 2020 and 2022. The total number of cybersecurity-related grants increased by an AAGR of 7% during the same period, according to GlobalData's patent analytics database.
Notably, the number of cybersecurity-related patent applications in the pharmaceutical industry was 281 since 2020, while 180 applications were granted.
The top five assignees by filings accounted for 31% of patent applications
Analysis of patent applications by assignee shows that Salk Institute for Biological Studies filed the most cybersecurity patents within the pharmaceutical industry since 2020. The company filed 17 cybersecurity-related patents since 2020.
It was followed by Galapagos (13 applications), Johnson & Johnson (11 applications), Takeda Pharmaceutical (10 applications) and British American Tobacco (8 applications).
The top five assignees by grants accounted for 41% of successful patent grants
Analysis of patent grants by assignee shows that Galapagos was granted 14 patents related to cybersecurity within the pharmaceutical industry since 2020. It was followed by Salk Institute for Biological Studies (12 grants), Takeda Pharmaceutical (12 grants), Sanofi (7 grants) and Voip-PAL.com (7 grants).
Patent activity was driven by the US with a 41% share of total patent publications
The largest share of cybersecurity-related patent publications in the pharmaceutical industry since 2020 was held by the US with 41%, followed by China (20%) and Japan (8%).
GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.
GlobalData’s Patents Analytics tracks patent filings and grants from official patent offices around the world. Proprietary analysis and official patent classifications are used to group patents into key thematic areas and link them to specific companies across the world’s largest industries
